Dawn Meyer

NPI: 1467575126
Total Payments
$218,550
2024 Payments
$44,230
Companies
9
Transactions
321
Medicare Patients
568
Medicare Billing
$76,463

Payment Breakdown by Category

Other$154,759 (70.8%)
Travel$32,899 (15.1%)
Consulting$23,888 (10.9%)
Food & Beverage$6,931 (3.2%)
Education$73.74 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $106,259 62 48.6%
Honoraria $48,500 25 22.2%
Travel and Lodging $32,899 105 15.1%
Consulting Fee $23,888 7 10.9%
Food and Beverage $6,931 120 3.2%
Education $73.74 2 0.0%

Top Paying Companies

Company Total Records Latest Year
Chiesi USA, Inc. $184,064 224 $0 (2024)
AstraZeneca Pharmaceuticals LP $30,116 65 $0 (2024)
Alexion Pharmaceuticals, Inc. $3,747 11 $0 (2022)
Abbott Laboratories $169.34 16 $0 (2024)
Novartis Pharmaceuticals Corporation $108.40 1 $0 (2022)
Siemens Medical Solutions USA, Inc. $108.40 1 $0 (2021)
Viz.ai, Inc. $104.94 1 $0 (2022)
BTG International, Inc. $103.59 1 $0 (2024)
CVRx, Inc. $27.35 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $44,230 67 Chiesi USA, Inc. ($39,776)
2023 $83,838 120 Chiesi USA, Inc. ($70,217)
2022 $67,963 109 Chiesi USA, Inc. ($54,806)
2021 $22,519 25 Chiesi USA, Inc. ($19,266)

All Payment Transactions

321 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
12/19/2024 Abbott Laboratories COROFLOW (Device) Food and Beverage In-kind items and services $8.07 General
Category: Vascular
12/19/2024 Abbott Laboratories COROFLOW (Device) Food and Beverage In-kind items and services $4.91 General
Category: Vascular
12/05/2024 Abbott Laboratories PRESSUREWIRE (Device) Food and Beverage In-kind items and services $5.32 General
Category: Vascular
12/05/2024 Abbott Laboratories COROFLOW (Device) Food and Beverage In-kind items and services $4.03 General
Category: Vascular
11/21/2024 Abbott Laboratories DIAMONDBACK CORONARY (Device) Food and Beverage In-kind items and services $18.34 General
Category: Vascular
11/13/2024 Chiesi USA, Inc. CLEVIPREX (Drug), KENGREAL Food and Beverage Cash or cash equivalent $41.67 General
Category: CARDIOVASCULAR
11/05/2024 Abbott Laboratories COROFLOW (Device) Food and Beverage In-kind items and services $7.39 General
Category: Vascular
10/31/2024 Chiesi USA, Inc. CLEVIPREX (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,000.00 General
Category: CARDIOVASCULAR
10/31/2024 Chiesi USA, Inc. CLEVIPREX (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,000.00 General
Category: CARDIOVASCULAR
10/30/2024 Chiesi USA, Inc. CLEVIPREX (Drug) Travel and Lodging Cash or cash equivalent $516.95 General
Category: CARDIOVASCULAR
10/23/2024 Abbott Laboratories COROFLOW (Device) Food and Beverage In-kind items and services $8.21 General
Category: Vascular
10/23/2024 Abbott Laboratories COROFLOW (Device) Food and Beverage In-kind items and services $7.00 General
Category: Vascular
10/23/2024 Abbott Laboratories COROFLOW (Device) Food and Beverage In-kind items and services $6.33 General
Category: Vascular
10/16/2024 Chiesi USA, Inc. Consulting Fee Cash or cash equivalent $2,100.00 General
10/16/2024 BTG International, Inc. Food and Beverage In-kind items and services $103.59 General
09/26/2024 Chiesi USA, Inc. CLEVIPREX (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,000.00 General
Category: CARDIOVASCULAR
09/24/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,150.00 General
Category: Rare Disease
09/18/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $121.94 General
Category: Rare Disease
09/18/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Travel and Lodging In-kind items and services $26.80 General
Category: Rare Disease
09/18/2024 Abbott Laboratories PRESSUREWIRE (Device) Food and Beverage In-kind items and services $6.60 General
Category: Vascular
09/18/2024 Abbott Laboratories COROFLOW (Device) Food and Beverage In-kind items and services $6.07 General
Category: Vascular
09/18/2024 Abbott Laboratories COROFLOW (Device) Food and Beverage In-kind items and services $2.72 General
Category: Vascular
09/14/2024 Abbott Laboratories COROFLOW (Device) Food and Beverage In-kind items and services $20.63 General
Category: Vascular
08/05/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $6.46 General
Category: Rare Disease
08/01/2024 Chiesi USA, Inc. CLEVIPREX (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: CARDIOVASCULAR

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 161 209 $100,402 $19,682
2022 2 106 139 $76,984 $15,309
2021 2 176 247 $127,963 $26,745
2020 4 125 163 $63,836 $14,728
Total Patients
568
Total Services
758
Medicare Billing
$76,463
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 76 81 $55,728 $9,628 17.3%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 50 90 $31,950 $7,415 23.2%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 14 15 $7,020 $1,364 19.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 21 23 $5,704 $1,274 22.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 74 83 $57,104 $11,248 19.7%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 32 56 $19,880 $4,061 20.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 119 136 $90,168 $18,755 20.8%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 57 111 $37,795 $7,989 21.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 44 79 $25,280 $5,873 23.2%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 30 30 $18,600 $4,189 22.5%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 28 30 $12,540 $2,939 23.4%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2020 23 24 $7,416 $1,727 23.3%

About Dawn Meyer

Dawn Meyer is a Family healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1467575126.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dawn Meyer has received a total of $218,550 in payments from pharmaceutical and medical device companies, with $44,230 received in 2024. These payments were reported across 321 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($106,259).

As a Medicare-enrolled provider, Meyer has provided services to 568 Medicare beneficiaries, totaling 758 services with total Medicare billing of $76,463. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location San Diego, CA
  • Active Since 04/09/2007
  • Last Updated 01/16/2019
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1467575126

Products in Payments

  • CLEVIPREX (Drug) $169,553
  • ANDEXXA (Biological) $30,718
  • KENGREAL (Drug) $3,912
  • Andexxa (Drug) $3,117
  • ARTIS icono biplane (Device) $108.40
  • LEQVIO (Drug) $108.40
  • Viz.AI LVO (Device) $104.94
  • COROFLOW (Device) $75.36
  • DIAMONDBACK CORONARY (Device) $36.87
  • Barostim Neo System (Device) $27.35
  • OPTIS (Device) $25.28
  • AMPLATZER (Device) $19.91
  • BRILINTA (Drug) $12.06
  • PRESSUREWIRE (Device) $11.92

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in San Diego